Semaglutide & MASH: New Hope for Liver Disease?

Semaglutide’s Unexpected Liver Benefit: A Paradigm Shift in NAFLD Treatment? Nearly 40% of adults globally are estimated to have non-alcoholic fatty liver disease (NAFLD), a figure poised to surge alongside … Read More